Precision Biology solutions focused on multiplexed analysis of cells and tissue with applications in both research and clinical diagnostics

RareCyte News

RareCyte® announces a new biomarker liquid biopsy assay for the neuroendocrine marker, synaptophysin (SYP), enabling customers to evaluate SYP expression on circulating tumor cells (CTCs) with industry leading accuracy and precision in patients with prostate cancer
more →

RareCyte® announces a new dual biomarker liquid biopsy assay for androgen receptor splice variant 7 (ARv7) and the neuroendocrine marker, synaptophysin (SYP)
more →

Upcoming Events

Don’t miss this upcoming virtual workshop with industry leaders and a special session on “Unlocking Spatial Biology with Orion” by Dr. Tad George. Register Today →

Join Eric Kaldjian, MD, our Chief Medical Officer on September 15th as he presents “Resolving the Complexity of Tissue Immune Response with Orion High-Dimensional Imaging”. This talk will describe the application of 17-plex immuno-oncology fluorescence panel and H & E images on the same tissue sections, all in a single scan, single stain process. Register Today →

Pharma Programs

“The RareCyte CTC system has been analytically validated in our CAP/CLIA Laboratory and the validation and acceptance criteria met the needs of the clinical drug study team. In partnership with a global CRO, the CTC workflow is being successfully implemented.”

   – Jeff Fill, Senior Director, Diagnostic and Experimental Pathology, Eli Lilly and Company
more →